Historical record - last NADAC effective date: 1/1/2016
Product Information
BOTOX 200 UNITS VIAL is a brand product labeled by Allergan, Inc., priced at $1155.6819 per EA under NDC 00023392102. Its NADAC has been published 156 times since Jan 22, 2014.
Strength
200 [USP'U]/1
Manufacturer
Allergan, Inc.NDC
00023392102
Classification
Brand
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRADERMAL; INTRAMUSCULAR
Effective Date
1/1/2016
Active Ingredients
BOTULINUM TOXIN TYPE AApproval Type
Biologic (BLA)
FDA Application
BLA103000On Market Since
1/11/2010
Pharmacological Classes
Price Statistics
The NADAC for BOTOX 200 UNITS VIAL has been published 156 times since Jan 22, 2014, and over the history we have for it it has risen 7.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1155.6819 per EA |
|---|---|
| All-time high | $1155.6819 (Jan 11, 2017) |
| All-time low | $1079.8420 (Jan 22, 2014) |
| Median price | $1113.7707 |
| Average price | $1116.9177 |
| Largest weekly change | +3.8% (Jan 13, 2016) |
| Weeks tracked | 156 |
| Tracking since | Jan 22, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+7.0%
Last surveyed Jan 11, 2017 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the onabotulinumtoxinA market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Allergan, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
onabotulinumtoxinA market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BOTOX 200 UNITS VIAL?
The current National Average Drug Acquisition Cost (NADAC) for BOTOX 200 UNITS VIAL, manufactured by Allergan, Inc., is $1155.6819 per EA (NDC 00023392102), effective Jan 11, 2017.
How has the price of BOTOX 200 UNITS VIAL changed over time?
Over the history we have for it, the NADAC for BOTOX 200 UNITS VIAL has risen 7.0%. It has been tracked across 156 weekly CMS publications since Jan 22, 2014.
What are the highest and lowest recorded NADAC prices for BOTOX 200 UNITS VIAL?
Since Jan 22, 2014, the NADAC for BOTOX 200 UNITS VIAL has ranged from a low of $1079.8420 (Jan 22, 2014) to a high of $1155.6819 (Jan 11, 2017), with a median of $1113.7707 per EA.
Are there cheaper alternatives to BOTOX 200 UNITS VIAL?
No other NADAC-published product currently shares the active ingredient and strength of BOTOX 200 UNITS VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BOTOX 200 UNITS VIAL?
BOTOX 200 UNITS VIAL (NDC 00023392102) is labeled by Allergan, Inc., and CMS classifies it as a brand product.